Topics in Clinical Pharmacology: Ganciclovir
- 1 October 1992
- journal article
- review article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 304 (4) , 272-277
- https://doi.org/10.1097/00000441-199210000-00010
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovirAntimicrobial Agents and Chemotherapy, 1991
- Susceptibility of Human Herpesvirus 6 to Antivirals In VitroThe Journal of Infectious Diseases, 1990
- Antiviral Activity and Mechanism of Action of GanciclovirClinical Infectious Diseases, 1988
- The susceptibility of adenovirus infection to the anti-cytomegalovirus drug, ganciclovir (DHPG)FEMS Microbiology Letters, 1988
- Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegalovirusesAntimicrobial Agents and Chemotherapy, 1985
- Inhibition of murine cytomegalovirus lung infection and interstitial pneumonitis by acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanineAntimicrobial Agents and Chemotherapy, 1985
- Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus.Proceedings of the National Academy of Sciences, 1985
- Inhibition of human cytomegalovirus replication by 9-(1,3-dihydroxy-2-propoxymethyl)guanine alone and in combination with human interferonsAntimicrobial Agents and Chemotherapy, 1984
- Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitroAntimicrobial Agents and Chemotherapy, 1983
- Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanineAntimicrobial Agents and Chemotherapy, 1983